EMS

Brazil ANVISA expands product safety enforcement

38 clusters · 270 sources · last updated 5 days ago

Latest: Anvisa bans irregular insulin and peptide sales in Brazil

Since May 2026, Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics, and consumer goods. Early actions included suspending batches of statins

Brazil trade diversification and China engagement

19 clusters · 162 sources · last updated 6 days ago

Latest: Brazil and China expand cooperation in infrastructure and agricultural technology

Brazil is advancing a dual strategy of trade diversification and healthcare modernization to bolster national sovereignty. To mitigate the impact of United States tariffs, which Minister Márcio Elias Rosa has labeled ‘il

Advancements in obesity and diabetes medications

2 clusters · 6 sources · last updated 9 days ago

Latest: Obesity drugs show up to 30% weight loss at EASD 2026

Developments in obesity and diabetes treatments have focused on both regulatory approvals and clinical efficacy data. In Brazil, the National Health Surveillance Agency (Anvisa) approved generic registrations for liraglu

Semaglutide regulatory approvals and pricing in Brazil

8 clusters · 112 sources · last updated 28 days ago

Latest: Brazil expands access to obesity and diabetes treatments

Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject